Lisdexamfetamine Dimesylate

Rank #314 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$35.7M

Total Cost

Share:

88,692

Total Claims

$35.7M

Total Cost

4,154

Prescribers

$403

Cost per Claim

2,334

Beneficiaries

91,717

30-Day Fills

$8,594

Avg Cost/Provider

21

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$35.7M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $35.7M total

🔎 Data Overview

👤

Average cost of $15,296 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Lisdexamfetamine Dimesylate

#ProviderSpecialtyLocationClaimsCost
1Glenda McconnellNurse PractitionerGreen Bay, WI242$117K
2Edward SathoffPsychiatryMankato, MN256$107K
3Richard WinerPsychiatry & NeurologyRoswell, GA138$78K
4Pamela PageNurse PractitionerDe Pere, WI174$77K
5Debra BenishekNurse PractitionerGreen Bay, WI148$75K
6Kim WolfNurse PractitionerNew Berlin, WI142$68K
7Glenn ArchibaldPsychiatryAnniston, AL147$58K
8Jessica StevensNurse PractitionerAdams, WI148$55K
9Simon McclurePsychiatryBridgeport, WV137$55K
10Jordan WilsonPhysician AssistantCentralia, WA133$54K
11David AnakwenzePsychiatryFlorence, AL135$52K
12Thomasina WranghamNurse PractitionerMarion, IN132$52K
13Charles MayoPsychiatrySaint Croix Falls, WI131$52K
14Willis HollowayPsychiatryOklahoma City, OK124$49K
15Edmond YoungPsychiatryGladstone, MO85$48K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
311Naloxegol Oxalate (Movantik)$36.1M85,094
312Valacyclovir Hcl (Valacyclovir)$35.9M827,731
313Sodium Oxybate (Xyrem)$35.8M2,160
314Lisdexamfetamine Dimesylate (Lisdexamfetamine Dimesylate)$35.7M88,692
315Ketoconazole (Ketoconazole)$35.4M1,346,512
316Oxcarbazepine (Oxcarbazepine)$35.3M430,248
317Trametinib Dimethyl Sulfoxide (Mekinist)$35.0M2,448

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology